---
run_id: halo-evidence-vs-diagnosis-validation-v12-vanilla-07
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v12
benchmark_version: halo-evidence-vs-diagnosis-validation-v12-v1
model_condition: vanilla
run_number: 7
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 2048
seed: 701
prompt_source: condition packet (vanilla) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 81621976eaf302301d88434e895bffe7f264ddbe9d86bbb0dd82120c2f65f2aa
source_packet: the frozen Advisor prompt alone, with no added material - see run-packet.md
source_packet_sha256: 81621976eaf302301d88434e895bffe7f264ddbe9d86bbb0dd82120c2f65f2aa
condition_packet_sha256: 81621976eaf302301d88434e895bffe7f264ddbe9d86bbb0dd82120c2f65f2aa
output_file: model-outputs/vanilla-07.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - vanilla (run 07)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v12-v1`, condition `vanilla`, run 7 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 701, on the frozen condition packet.

## Output

I recommend the **Case Evidence Review**.

### The Recommendation
You should advise the CEO to commit to the Case Evidence Review. While the executive team is celebrating "commercial discipline," your data suggests you are currently experiencing a **false positive**.

The expansion bookings were driven by pricing incentives (the bundle), not product value. The usage spike is "vanity usage" (managers rehearsing samples) rather than "value usage" (analysts solving cases). Most critically, you have a looming retention cliff with regional administrators and a fundamental "explainability" failure in the public sector.

Scaling now would be scaling an unstable foundation; the Adoption Quality Sprint only tracks *if* they use it, not *why* they stop; and the Demand Cleanroom tells you if people will pay for it, but not how to fix the product so they *want* to keep paying for it. You must determine if PlanPilot is actually solving the workflow problem or if it is simply a sophisticated drafting tool that analysts abandon once the "newness" wears off.

### The Strongest Reason Against It
**Velocity and Executive Optics.** This is the slowest, most manual of the three validation options. After a "surprisingly strong quarter," the executive team is in a celebratory mood and feels they have found the winning formula. Recommending a deep-dive audit into "overridden" and "impossible to explain" suggestions feels like applying the brakes during a sprint. It risks painting the product team as overly cautious or "academic" at a moment when Sales wants to capitalize on momentum.

### Evidence That Would Change My Mind
I would pivot to the **Demand Cleanroom** if you discover that the "impossible to explain" feedback is limited strictly to a tiny, idiosyncratic subset of public-sector users and that the "manual notes" fallback used by analysts is actually a preference for documentation style rather than a failure of the tool's logic. If the product is fundamentally sound and the friction is merely a "sales packaging" or "training" issue, you don't need to audit the cases—you need to test if the market will pay full price without the bundle.
